EVO

Evotec SE

GLP-certifiedAccepting studies

Discovery & translational preclinical across modalities.

Preclinical / GLP laboratoryHamburg, GermanyEuropeEst. 1993 · 33y5,000 staffWebsite

Open room Compare

Overview Capabilities Study capabilities Animal models Regulatory Locations Team

Animal-model database

Extensive model portfolio · 85

Illustrative — species, strains, disease models, regulatory acceptance & availability.

Species / strain	Model type	Disease area	Regulatory	Availability
MouseC57BL/6	Inbred strain	Immunology	FDA/EMA accepted	Readily available · 20,000 cap.
MouseBALB/c	Inbred strain	—	FDA/EMA accepted	Readily available · 15,000 cap.
MouseNSG (NOD scid gamma)	Humanized	Immuno-oncology	Emerging	Readily available · 5,000 cap.
MouseCell-line xenograft (CDX)	Tumor xenograft	Oncology	Research-use	Readily available
MousePatient-derived xenograft (PDX)	Tumor xenograft	Oncology	Research-use	By request
RabbitNew Zealand White	Outbred strain	Repro / teratology	FDA/EMA accepted	Readily available · 2,000 cap.
RatSprague-Dawley	Outbred strain	General toxicology	FDA/EMA accepted	Readily available · 12,000 cap.
RatWistar Han	Outbred strain	—	FDA/EMA accepted	Readily available · 8,000 cap.
ZebrafishAB wild-type	Disease-specific	Developmental / safety screen	Research-use	Readily available · 30,000 cap.

EVO

Evotec SE

Preclinical / GLP · Germany

Live record · illustrative seed data · scores deterministic, rules-based — not AI · regulatory signals are educational, not a compliance determination.